The PE Ratio as of September 2024 (TTM) for Artelo Biosciences, Inc. (ARTL) is -0.36

According to Artelo Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.36. This represents a change of -48.15% compared to the average of -0.69 of the last 4 quarters.

Artelo Biosciences, Inc. (ARTL) Historical PE Ratio (quarterly & annually)

How has ARTL PE Ratio performed in the past?

The mean historical PE Ratio of Artelo Biosciences, Inc. over the last ten years is -64.81. The current -0.36 PE Ratio has changed -44.45% with respect to the historical average. Over the past ten years (40 quarters), ARTL's PE Ratio was at its highest in in the November 2013 quarter at 0. The PE Ratio was at its lowest in in the August 2014 quarter at -24958.25.

Artelo Biosciences, Inc. (ARTL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Artelo Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Artelo Biosciences, Inc. (ARTL) Average PE Ratio

How has ARTL PE Ratio performed in the past?

The current PE Ratio of Artelo Biosciences, Inc. (ARTL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Artelo Biosciences, Inc. (ARTL) PE Ratio vs. Peers

How is ARTL’s PE Ratio compared to its peers?

Artelo Biosciences, Inc.’s PE Ratio is greater than Aileron Therapeutics, Inc. (-2.21), less than Histogen Inc. (-0.10), greater than Curis, Inc. (-0.61), less than Timber Pharmaceuticals, Inc. (-0.07), less than Salarius Pharmaceuticals, Inc. (-0.14), greater than Vaccinex, Inc. (-0.58), greater than Fresh Tracks Therapeutics, Inc. (-0.78), less than Basilea Pharmaceutica AG (0), less than Ascletis Pharma Inc. (25.48), greater than AVAX Technologies, Inc. (-55.70), less than Brii Biosciences Limited (-0.00), greater than Pasithea Therapeutics Corp. (-1.43), less than Nutriband Inc. (-0.27), greater than ZIVO Bioscience, Inc. (-6.76), greater than MediciNova, Inc. (-2.46), greater than Eliem Therapeutics, Inc. (-12.61), greater than Akari Therapeutics, Plc (-3.49), greater than Axcella Health Inc. (-1.55), greater than Magenta Therapeutics, Inc. (-10.73), less than null (-0.04),

Build a custom stock screener for Artelo Biosciences, Inc. (ARTL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Artelo Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Artelo Biosciences, Inc. (ARTL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Artelo Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.